STAT3 and cancer: Several studies have documented that aberrant activation of the STAT3 signaling pathway contributes to neoplastic transformation in various malignancies, and have validated STAT3 as a promising target for cancer therapy [8].The development of agents that target STAT3 with adequate potency and tumor selectivity has proven to be a difficult task.